Lista de obras -

A low selenium level is associated with lung and laryngeal cancers

artículo científico publicado en 2013

An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

artículo científico publicado en 2015

Arsenic (As) and breast cancer risk

artículo científico publicado en 2012

Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.

artículo científico publicado en 2016

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

artículo científico publicado en 2015

Association of zinc level and polymorphism in MMP-7 gene with prostate cancer in Polish population

artículo científico publicado en 2018

BRCA1 promoter methylation in peripheral blood is associated with the risk of triple-negative breast cancer

scientific article published on 29 September 2019

Blood and serum samples collection and storage for further selenium measurements

artículo científico publicado en 2012

CHAPTER 22. Selenium and Cancer

artículo científico publicado en 2015

Can selenium levels act as a marker of colorectal cancer risk?

artículo científico publicado en 2013

Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2014

Copper as diagnostic marker of cancers.

artículo científico publicado en 2015

Correction: A Low Selenium Level Is Associated with Lung and Laryngeal Cancers

artículo científico publicado en 2013

Correction: Serum selenium levels and the risk of progression of laryngeal cancer

artículo científico publicado en 2018

Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers

artículo científico publicado en 2017

Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

artículo científico publicado en 2016

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

artículo científico publicado en 2017

Identification of six new susceptibility loci for invasive epithelial ovarian cancer

artículo científico publicado en 2015

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

artículo científico publicado en 2017

Influence of the selenium level on overall survival in lung cancer

artículo científico publicado en 2019

Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

artículo científico publicado en 2016

Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer

artículo científico publicado en 2011

Iron and breast cancer risk

artículo científico publicado en 2012

Iron as diagnostic marker of cancer.

artículo científico publicado en 2015

Iron levels, genes involved in iron metabolism and antioxidative processes and lung cancer incidence

artículo científico publicado en 2019

Magnesium as a diagnostic marker of cancer.

artículo científico publicado en 2015

Meeting abstracts from the Annual Conference on Hereditary Cancers 2015: Szczecin, Poland. 24-25 September, 2015.

artículo científico publicado en 2017

Meeting abstracts from the Annual Conference on Hereditary Cancers 2016: Szczecin, Poland. 14-15 September 2016.

artículo científico publicado en 2017

Microelements as diagnostic markers of pancreatic cancer.

artículo científico publicado en 2015

Microelements as risk factors for cancer of the lung and larynx

artículo científico publicado en 2012

Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations

artículo científico publicado en 2018

Plasma micronutrients, trace elements, and breast cancer in BRCA1 mutation carriers: an exploratory study

scientific article published on 11 May 2012

Polymorphisms in MMP-1, MMP-2, MMP-7, MMP-13 and MT2A do not contribute to breast, lung and colon cancer risk in polish population

scientific article published on 31 July 2020

Prospective observation of breast/ovarian cancer risk in BRCA1 carriers depending on serum selenium level optimized with diet

artículo científico publicado en 2012

Selenium (Se) and breast cancer risk

Selenium (Se) and the risk of breast, ovarian and prostate cancers

artículo científico publicado en 2012

Selenium and cancer risk in CHEK2 mutation carriers

Selenium and gastrointestinal cancers risk

artículo científico publicado en 2012

Selenium and genotypes as marker of risk in BRCA1 mutation carriers

artículo científico publicado en 2012

Selenium and risk of bladder cancer

Selenium and the risk of cancer of the lung and larynx. A case-control study from a region with low selenium.

artículo científico publicado en 2012

Selenium and the risk of cancers of the colon, pancreas and stomach

artículo científico publicado en 2012

Selenium as a marker of cancer risk and of selection for control examinations in surveillance

artículo científico publicado en 2015

Selenium as diagnostic marker of cancers.

artículo científico publicado en 2015

Selenium as marker for cancer risk and prevention

artículo científico publicado en 2012

Serum 25(OH)D concentration, common variants of the VDR gene and lung cancer occurrence

artículo científico publicado en 2017

Serum Concentrations of Selenium and Copper in Patients Diagnosed with Pancreatic Cancer

artículo científico publicado en 2015

Serum concentration of iron as predictor of cancer risk among BRCA1 mutation carriers.

artículo científico publicado en 2012

Serum concentration of selected macro- and microelements and their correlation with the risk of breast and ovarian cancer among BRCA1 mutation carriers

Serum concentrations of Cu, Se, Fe and Zn in patients diagnosed with pancreatic cancer

artículo científico publicado en 2015

Serum folate concentration and the incidence of lung cancer

artículo científico publicado en 2017

Serum selenium level and cancer risk: a nested case-control study

scientific article published on 23 December 2019

Serum selenium levels and the risk of progression of laryngeal cancer

artículo científico publicado en 2018

The influence of selenium concentration and variations in selenoprotein genes on the CHEK2-dependent cancers

artículo científico publicado en 2015

Zinc and breast cancer risk

artículo científico publicado en 2012

Zinc as diagnostic marker of cancers.

artículo científico publicado en 2015

Lista de obras de

A low selenium level is associated with lung and laryngeal cancers

An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

Arsenic (As) and breast cancer risk

Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

Association of zinc level and polymorphism in MMP-7 gene with prostate cancer in Polish population

BRCA1 promoter methylation in peripheral blood is associated with the risk of triple-negative breast cancer

Blood and serum samples collection and storage for further selenium measurements

CHAPTER 22. Selenium and Cancer

Can selenium levels act as a marker of colorectal cancer risk?

Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

Copper as diagnostic marker of cancers.

Correction: A Low Selenium Level Is Associated with Lung and Laryngeal Cancers

Correction: Serum selenium levels and the risk of progression of laryngeal cancer

Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers

Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

Identification of six new susceptibility loci for invasive epithelial ovarian cancer

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Influence of the selenium level on overall survival in lung cancer

Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer

Iron and breast cancer risk

Iron as diagnostic marker of cancer.

Iron levels, genes involved in iron metabolism and antioxidative processes and lung cancer incidence

Magnesium as a diagnostic marker of cancer.

Meeting abstracts from the Annual Conference on Hereditary Cancers 2015: Szczecin, Poland. 24-25 September, 2015.

Meeting abstracts from the Annual Conference on Hereditary Cancers 2016: Szczecin, Poland. 14-15 September 2016.

Microelements as diagnostic markers of pancreatic cancer.

Microelements as risk factors for cancer of the lung and larynx

Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations

Plasma micronutrients, trace elements, and breast cancer in BRCA1 mutation carriers: an exploratory study

Polymorphisms in MMP-1, MMP-2, MMP-7, MMP-13 and MT2A do not contribute to breast, lung and colon cancer risk in polish population

Prospective observation of breast/ovarian cancer risk in BRCA1 carriers depending on serum selenium level optimized with diet

Selenium (Se) and breast cancer risk

Selenium (Se) and the risk of breast, ovarian and prostate cancers

Selenium and cancer risk in CHEK2 mutation carriers

Selenium and gastrointestinal cancers risk

Selenium and genotypes as marker of risk in BRCA1 mutation carriers

Selenium and risk of bladder cancer

Selenium and the risk of cancer of the lung and larynx. A case-control study from a region with low selenium.

Selenium and the risk of cancers of the colon, pancreas and stomach

Selenium as a marker of cancer risk and of selection for control examinations in surveillance

Selenium as diagnostic marker of cancers.

Selenium as marker for cancer risk and prevention

Serum 25(OH)D concentration, common variants of the VDR gene and lung cancer occurrence

Serum Concentrations of Selenium and Copper in Patients Diagnosed with Pancreatic Cancer

Serum concentration of iron as predictor of cancer risk among BRCA1 mutation carriers.

Serum concentration of selected macro- and microelements and their correlation with the risk of breast and ovarian cancer among BRCA1 mutation carriers

Serum concentrations of Cu, Se, Fe and Zn in patients diagnosed with pancreatic cancer

Serum folate concentration and the incidence of lung cancer

Serum selenium level and cancer risk: a nested case-control study

Serum selenium levels and the risk of progression of laryngeal cancer

The influence of selenium concentration and variations in selenoprotein genes on the CHEK2-dependent cancers

Zinc and breast cancer risk

Zinc as diagnostic marker of cancers.